These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3898283)

  • 21. Effect of two new immunomodulators on normal and burn injury neutrophils and macrophages.
    Waymack JP; Miskell P; Gonce SJ; Alexander JW
    J Burn Care Rehabil; 1987; 8(1):9-14. PubMed ID: 3553203
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunostimulant properties of aspartic acid].
    Belokrylov GA
    Biull Eksp Biol Med; 1986 Aug; 102(8):213-5. PubMed ID: 3527301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo enhancement of NK-cell activity by thymopentin.
    Hu C; Radelli L; Scorza R; Bonara P; Perego R; Fantuzzi G
    Int J Immunopharmacol; 1990; 12(2):193-7. PubMed ID: 2184134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
    Ochoa EL; Medrano S; de Carlin MC; Dilonardo AM
    Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 27. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA; Audhya T; Kroon D; Goldstein G
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide.
    Laghi Pasini F; Auteri A; Ceccatelli L; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):316-22. PubMed ID: 7018516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymopoietin to thymopentin: experimental studies.
    Goldstein G; Audhya TK
    Surv Immunol Res; 1985; 4 Suppl 1():1-10. PubMed ID: 2994196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymopentin treatment in genital warts of long duration.
    Fransen L; Anthoons J; Hoogewijs G; Bolla K
    Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of TP-5 on the production of C3, PGE2, and TXB2 by macrophages obtained from burned guinea pigs.
    Ogle CK; Ogle JD; Keynton L; Nagy H; Alexander JW
    J Burn Care Rehabil; 1989; 10(2):146-50. PubMed ID: 2651450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.
    Faist E; Markewitz A; Fuchs D; Lang S; Zarius S; Schildberg FW; Wachter H; Reichart B
    Ann Surg; 1991 Sep; 214(3):264-73; discussion 274-5. PubMed ID: 1929608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.
    Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH
    J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologically active analogs of thymopentin with enhanced enzymatic stability.
    Heavner GA; Kroon DJ; Audhya T; Goldstein G
    Peptides; 1986; 7(6):1015-9. PubMed ID: 3031628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of TP-5 and its analogs on skin grafts in mice.
    Szende B; Kisfaludy L; Lapis K; Dénes L; Szporny L; Nyéke O; Schön I; Hajós G; Ember J; Constantin M
    J Immunopharmacol; 1985; 7(1):67-78. PubMed ID: 3891868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological status of patients with recurrent herpes simplex infections. In vitro effect of thymopoietin and splenin-derived and partially modified peptides on peripheral blood lymphocytes in comparison to a thymus extract].
    Simon HU; Roth H; Forner K; Haroske D
    Allerg Immunol (Leipz); 1990; 36(2):111-8. PubMed ID: 1975471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation by thymopoietin oligopeptides of lectin-dependent cell-mediated cytotoxicity in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Nékám K; Gergely P; Fehér J
    J Clin Lab Immunol; 1985 Nov; 18(3):119-22. PubMed ID: 3910838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of thymopentin and recombinant interferon alpha 2A on the biochemiluminescence of neutrophil granulocytes in subjects with HIV infections].
    Latorre A; Romagno D; Palumbo A; Dammacco F
    G Clin Med; 1987; 68(6-7):351-5. PubMed ID: 3308608
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
    Faist E; Riedel A; Bolla K
    Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.